Per Norlen | Chief Executive Officer |
Jesper Nyegaard Nissen | Chief Operating Officer and Interim Chief Financial Officer |
Thomas Flaten | Lake Street |
Ahu Demir | Ladenburg Thalmann |
Swayampakula Ramakanth | H.C. Wainwright |
Good day, and thank you for standing by. Welcome to the Evaxion Biotech Q2 Results Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.